References
Changing the process of prescribing to procuring lymphoedema compression garments: a service evaluation
Abstract
Compression garments are the mainstay of lymphoedema treatment, yet the process of obtaining by prescription is lengthy, governed by funding, involves numerous professionals with little patient value and often involes copious inaccuracies, delays and errors. This service evaluation estimates the potential impact of changing the way compression garments are accessed from a prescription to a procurement process. The main objective was to estimate the impact and costs of altering the process within the NHS Wales setting. A service evaluation was formally supported by Medicine Management and Lymphoedema Wales Strategy Board to compare the prescription process to a new procuring route. A form was devised so that data was could be collected over 12 months by lymphoedema therapists on each compression garment issued to patients attending two lymphoedema services in NHS Wales. The data collected included information on the garment ordered, costs (prescribed compared to procured), timing between garment ordered and received plus a comparison of the processes. All non-patient identifiable data was entered into a database and comparison analysis was completed to identify any correlations between the variables collected. The project was ratified by research and development as service evaluation. There was a total of 5392 completed patient data forms were included, which when compared to the processes indicated that using a prescription route is overwhelmingly more costly than procuring. Overall costs suggest the potential for substantial savings to NHS Wales (£71.10 per patient) were statistically significant (P<0.001). Potential for improved patient outcomes was observed as garments were provided directly on appointment instead of significant delays promoting value-based healthcare.
Lymphoedema is a debilitating, enduring condition connected with several diseases including cancer. It is characterised by atypical swelling lasting for more than 3 months and can occur in any part of the body. Those affected may experience skin changes, pain, heaviness, recurrent cellulitis, reduced mobility and psychological distress (Morgan et al, 2005; Greene and Meskell, 2016; Thomas et al, 2020). Evidence suggests that the impact of Lymphoedema on an individual’s health, wellbeing, sense of self and quality of life may be profound (Thomas et al, 2020; Greene and Meskell, 2016). As a chronic condition, lymphoedema can have a significant impact on health outcomes and results in a substantial burden to the NHS (Atkin, 2016; Moffatt et al, 2016; Guest et al, 2016; Thomas et al, 2017). Lymphoedema requires ongoing management including skincare, exercise and the daily use of compression garments (Lymphoedema Framework, 2006). Since 2007, compression garments have been accessed through Part 1XA of the drug tariff in the UK, which covers appliances (NHS Business Services Authority, 2021a). Ineffective management of the prescription process alongside inappropriate prescribing of garments have been identified by patients and healthcare professionals as important issues.
Register now to continue reading
Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:
What's included
-
Limited access to our clinical or professional articles
-
New content and clinical newsletter updates each month